IL-6 signaling and breast cancer
US11187704B2 · kind B2 · utility
1Cited by
1References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 22, 2019 |
| Grant date | Nov 30, 2021 |
| Priority date | — |
| Expiry date | Jan 15, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/54
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The disclosure provides, inter alia, methods of detecting IL-6 signaling activity in T cells in breast cancer patients, such as breast cancer patients in remission.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.